Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Dogs Of The Dow Win In 2018: Will ETFs See Success In 2019?

Published 01/07/2019, 08:00 PM
Updated 07/09/2023, 06:31 AM

The U.S. markets took a massive hit in the fourth quarter of 2018, leading the S&P 500 to lose about 7.0% for the whole year. Factors like the Fed’s policy tightening, renewed global growth worries, an oil price slump, widespread tech selloffs, heightened trade tensions between the United States and China, fears of peaking U.S. economic growth, and finally the partial government shutdown weighed on the markets (read: 5 ETFs Up At Least 10% in Tumultuous Q4).

However, one investing corner — the ‘Dogs of the Dow’ — beat the market in spooky 2018, having lost only 1.5% despite sturdy yields. It easily beat the parent Dow Jones Industrial Average, which shed about 6% last year.

The Dogs of the Dow represents the 10 highest-yielding blue-chip companies of the Dow Jones Industrial Average, picked after the stock market closes on the last day of the year. As volatility roared in 2018, investors sought safety in these high dividend-yielding stocks. Merck (NYSE:MRK) , Pfizer (NYSE:PFE) , Cisco Systems (NASDAQ:CSCO) , Verizon (NYSE:VZ) , Coca Cola (NYSE:KO) and Procter & Gamble (NYSE:PG) drove the index last year.

The stocks that form the Dogs of the Dow are likely to change every year because the relative dividend yields keep changing, thanks to the components’ regular dividend hikes and the changes in stock prices. So, the outperformers often leave the Dogs list, allowing stocks that are in the oversold territory and that have seen their yields rising.

Will Dogs Be Successful in 2019?

After General Electric Co (NYSE:GE) was out of the Dow Jones Index last year, JPMorgan (NYSE:JPM) replaced it, marking the only change in the Dogs list for 2019. Overall, the new list includes Verizon, International Business Machines (NYSE:IBM) , Pfizer, Exxon Mobil (NYSE:XOM) , Chevron (NYSE:CVX) , Merck, Coca Cola, Cisco Systems, Procter & Gamble and JP Morgan.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The current fundamentals point to outperformance of the Dogs, even in 2019. This is because while a likely oil price recovery should boost two energy stocks, healthcare stocks are expected to maintain their outperformance this year as well.

A steepening of the yield curve, thanks to U.S. economic growth, should support JP Morgan while two tech stocks may rally on cheaper valuation. So, investors having faith in the Dogs of the Dow theory may find these ETFs interesting this year also.

ELEMENTS DJ High Yield Select 10 ETN (CY:DOD)

This is an ETN option and it seeks to implement the Dogs of the Dow investment strategy by investing in the ten stocks in the Dow Jones with the highest dividend yield. It charges 75 bps in annual fees. DOD is up 1.8% this year versus 0.5% gain of the Dow Jones (as of Jan 4, 2019).

ALPS Sector Dividend Dogs ETF SDOG

The index selects the five highest yielding securities in each of the 10 GICS sectors and equally weighing them. It charges 40 bps in annual fees and has gained 2.2% so far this year.

Invesco Dow Jones Industrial Average Dividend ETF DJD

The underlying index of the fund – the Dow Jones Industrial Average Yield Weighted index –provides exposure to high-yielding equity securities in the Dow Jones Industrial Average by their 12-month dividend yield over the prior 12 months. It charges 7 bps in fees and has added 0.2% so far this year (read: A Dividend ETF Investing Guide).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



Cisco Systems, Inc. (CSCO): Free Stock Analysis Report

International Business Machines Corporation (IBM): Free Stock Analysis Report

JPMorgan Chase & Co. (JPM): Free Stock Analysis Report

Merck & Co., Inc. (MRK): Free Stock Analysis Report

Pfizer Inc. (PFE): Free Stock Analysis Report

Verizon Communications Inc. (VZ): Free Stock Analysis Report

Coca-Cola Company (The) (KO): Free Stock Analysis Report

General Electric Company (GE): Free Stock Analysis Report

ALPS-SEC DV DOG (SDOG): ETF Research Reports

ELEMT-DOGS DOW (DOD): ETF Research Reports

GUGG-DJIA DVD (DJD): ETF Research Reports

Chevron Corporation (CVX): Free Stock Analysis Report

Exxon Mobil Corporation (XOM): Free Stock Analysis Report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.